Enteric fistula
Intestinal fistula refers to the appearance of a pathological channel between the intestines, between the intestines and other organs, or outside the body, which causes intestinal contents to flow out of the intestinal cavity, leading to a series of pathophysiological changes such as infection, fluid loss, malnutrition, and organ dysfunction.
-
Site of disease:
intestinal -
Infectious :
Not contagious -
Frequent population:
Surgery is common -
Related symptoms:
Stomach ache feces-like substance flowing out of the abdominal wound abdominal infection abdominal distension high fever -
Concurrent disease:
Related Drugs
Somatostatin for injection
Indication: This product is mainly used for: severe acute esophageal varicose bleeding; severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis; prevention and treatment of complications after pancreatic surgery; adjuvant treatment of pancreatic, biliary and intestinal fistulas; adjuvant treatment of diabetic ketoacidosis.
Manufacturer:
Shanghai Huayuan Pharmaceutical (Ningxia) Shasai Pharmaceutical Co., Ltd.
Somatostatin for injection
Indication: This product is mainly used for: severe acute esophageal varicose bleeding; severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis; prevention and treatment of complications after pancreatic surgery; adjuvant treatment of pancreatic, biliary and intestinal fistulas; adjuvant treatment of diabetic ketoacidosis.
Manufacturer:
Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Enteral Nutrition Emulsion (TP)
Indication: This product is suitable for patients with malnutrition or dietary disorders of gastrointestinal function, including patients after trauma or craniofacial and cervical surgery; patients with difficulty chewing and swallowing; patients with unclear consciousness or receiving mechanical ventilation; patients who need nutritional supplements after surgery; patients with anorexia nervosa, etc. This product does not contain dietary fiber and can be used for patients with severe gastrointestinal stenosis; patients with intestinal fistula; and preoperative or pre-diagnosis intestinal preparation.
Manufacturer:
Feisenyuskabi Huarui Pharmaceutical Co., Ltd.
Enteral Nutrition Emulsion (TP)
Indication: This product is suitable for patients with malnutrition or dietary disorders of gastrointestinal function, including patients after trauma or craniofacial and cervical surgery; patients with difficulty chewing and swallowing; patients with unclear consciousness or receiving mechanical ventilation; patients who need nutritional supplements after surgery; patients with anorexia nervosa, etc. This product does not contain dietary fiber and can be used for patients with severe gastrointestinal stenosis; patients with intestinal fistula; and preoperative or pre-diagnosis intestinal preparation.
Enteral Nutrition Emulsion (TP)
Indication: This product is suitable for patients with malnutrition or dietary disorders of gastrointestinal function, including patients after trauma or craniofacial and cervical surgery; patients with difficulty chewing and swallowing; patients with unclear consciousness or receiving mechanical ventilation; patients who need nutritional supplements after surgery; patients with anorexia nervosa, etc. This product does not contain dietary fiber and can be used for patients with severe gastrointestinal stenosis; patients with intestinal fistula; and preoperative or pre-diagnosis intestinal preparation.
Somatostatin
Indication: Esophageal venous bleeding caused by portal hypertension in cirrhosis; upper gastrointestinal bleeding caused by peptic ulcer, stress ulcer, and erosive gastritis; prevention and treatment of acute pancreatitis and its complications; adjuvant treatment of pancreatic, biliary, and intestinal fistulas; others: acromegaly, gastrinoma, insulinoma, and VIPoma
Manufacturer:
Shandong Newtime Pharmaceutical Co., Ltd.
Somatostatin
Indication: Esophageal venous bleeding caused by portal hypertension in cirrhosis; upper gastrointestinal bleeding caused by peptic ulcer, stress ulcer, and erosive gastritis; prevention and treatment of acute pancreatitis and its complications; adjuvant treatment of pancreatic, biliary, and intestinal fistulas; others: acromegaly, gastrinoma, insulinoma, and VIPoma
Manufacturer:
Shanghai Huayuan Pharmaceutical (Ningxia) Shasai Pharmaceutical Co., Ltd.
Somatostatin
Indication: Esophageal venous bleeding caused by portal hypertension in cirrhosis; upper gastrointestinal bleeding caused by peptic ulcer, stress ulcer, and erosive gastritis; prevention and treatment of acute pancreatitis and its complications; adjuvant treatment of pancreatic, biliary, and intestinal fistulas; others: acromegaly, gastrinoma, insulinoma, and VIPoma
Manufacturer:
Shanghai Huayuan Pharmaceutical (Ningxia) Shasai Pharmaceutical Co., Ltd.
Somatostatin for injection
Indication: This product is mainly used for: severe acute esophageal varicose bleeding; severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis; prevention and treatment of complications after pancreatic surgery; adjuvant treatment of pancreatic, biliary and intestinal fistulas; adjuvant treatment of diabetic ketoacidosis.
Somatostatin for injection
Indication: This product is mainly used for: severe acute esophageal varicose bleeding; severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis; prevention and treatment of complications after pancreatic surgery; adjuvant treatment of pancreatic, biliary and intestinal fistulas; adjuvant treatment of diabetic ketoacidosis.
Manufacturer:
Qingdao Guoda Biopharmaceutical Co., Ltd.
Related Ingredients
-
Somatostatin list
51110-01-1 -
Α-protein list
146317-23-9 -
fatty acid list
9150-89-4